Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE2
40 participants
INTERVENTIONAL
2026-02-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sex Differences in Attentional Bias in Marijuana-dependent Individuals
NCT01179425
Gender/Sex & CUD Remission
NCT04964739
SCORE Emerging Adult Cannabis Use & Stress
NCT05885542
Cannabis Reduction and Functional Outcomes
NCT07218471
Cannabis and Processing Emotions Study
NCT06907979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Males
Dronabinol
Oral dronabinol capsules (40 mg)
Placebo
Matched placebo capsules
Females
Dronabinol
Oral dronabinol capsules (40 mg)
Placebo
Matched placebo capsules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dronabinol
Oral dronabinol capsules (40 mg)
Placebo
Matched placebo capsules
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* DSM-5 criteria for CUD
* Cannabis use ≥4 days/week
* THC-positive urine
* BMI 18-30
* Regular menstrual cycle (females)
* Willingness to use non-hormonal birth control (females)
Exclusion Criteria
* Recent drug use other than cannabis
* Current psychotropic medication
* Treatment-seeking for SUD
* Current psychiatric disorder (except mild alcohol, nicotine, or caffeine use disorder)
* Pregnancy/nursing
* MRI contraindications
21 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute on Drug Abuse (NIDA)
NIH
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin Martin, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00148223
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.